US equities |
SPCX $167.12 ▲+5.13% NVDA $236.38 ▲+1.04% MU $1,064.49 ▼-0.97% TSLA $378.40 ▲+2.11% MSFT $525.11 ▲+1.46% SNDK $1,709.37 ▼-0.62% INTC $117.41 ▼-1.61% META $743.26 ▲+2.09%
FinancialContent

Articles published by Mirum Pharmaceuticals

News headline image
Mirum’s LIVMARLI® Now Authorized in Canada for Cholestatic Pruritus in Patients with Alagille Syndrome
From Mirum Pharmaceuticals
Via Business Wire
Tickers MIRM